Monograph Capital, a life sciences venture firm based in the UK, partners with young companies and scientific entrepreneurs to fund and advance novel research, therapies, diagnostics, and digital innovations that improve healthcare outcomes. With offices in London and San Francisco, Monograph Capital brings deep experience, assets, and capabilities to help life sciences companies scale and succeed, bridging opportunities across North America and the UK/Europe.